- Home
- BBNX vs FINS Comparison
BBNX vs FINS Comparison
Compare BBNX & FINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBNX | FINS |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.1M | 418.0M |
| IPO Year | 2025 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BBNX | FINS |
|---|---|---|
| Price | $19.50 | $12.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $23.80 | N/A |
| AVG Volume (30 Days) | ★ 960.2K | 38.0K |
| Earning Date | 04-21-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 78.95 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $100,251,000.00 | N/A |
| Revenue This Year | $34.90 | N/A |
| Revenue Next Year | $34.63 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 53.94 | N/A |
| 52 Week Low | $8.80 | $12.38 |
| 52 Week High | $32.71 | $13.55 |
Technical Indicators
Market Signals| Indicator | BBNX | FINS |
|---|---|---|
| Relative Strength Index (RSI) | 59.80 | 47.69 |
| Support Level | $9.34 | $12.59 |
| Resistance Level | $20.74 | $13.04 |
| Average True Range (ATR) | 1.05 | 0.11 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 63.55 | 44.00 |
Price Performance
Historical ComparisonAbout BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
About FINS Angel Oak Financial Strategies Income Term Trust of Beneficial Interest
Angel Oak Financial Strats Income Term Trust is a non-diversified, closed-end management investment company. The fund's objective is to seek current income with a secondary objective of total return. In pursuing its investment objective, the fund invests mainly in debt issued by financial institutions, including subordinated debt, unrated debt, senior debt, and high-yield securities.